Navigation Links
MDS Designates Cancer its Major Charitable Cause on World Cancer Day
Date:2/4/2008

MDS Makes Three-Year Commitment to the International Union Against Cancer

TORONTO, Feb. 4 /PRNewswire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life sciences markets, declared its increased commitment to the fight against cancer today designating it as MDS' major charitable cause. MDS has launched employee awareness and fundraising events around the world and announced a donation of nearly $1 million over the next three years to the International Union Against Cancer (UICC).

MDS chose UICC, the world's largest non-governmental association of cancer-fighting organizations, because of its global mission to fight the disease. With the support of partners like MDS, UICC acts as a resource for action and a voice for change through prevention education programs, research projects, and other initiatives that can make a real difference in saving lives and improving the quality of life for cancer patients and their families throughout the world.

"We are thrilled to support the work of the International Union Against Cancer," said Stephen P. DeFalco, President and Chief Executive Officer of MDS Inc. "We have great employees at MDS who are committed to this fight both as a company and as individuals, not only on World Cancer Day but every day they come to work."

Each year, more than 11 million new cases of cancer are diagnosed and more than 7 million people die from cancer. Through its life sciences businesses, MDS wages a fight against cancer every day:

- MDS has identified oncology as a focus area of clinical research

activity and conducts cancer studies around the world as part of its

full set of contract research services.

- MDS partners with pharma and biotech customers using its isotope

technologies to develop new radiotherapeutics to treat cancers like

non-Hodgkin's lymphoma and primary liver cancer.

- MDS produces instruments and reagents researchers use to understand

the disease mechanisms and develop new drug therapies.

About MDS

MDS is a global life sciences company that provides market-leading products and services that our customers need for the development of drugs and the diagnosis and treatment of disease. We are a leading global provider of pharmaceutical contract research, medical isotopes for molecular imaging, radiotherapeutics, and analytical instruments. MDS has more than 5,500 highly skilled people in 29 countries. Find out more at http://www.mdsinc.com or by calling 1-888-MDS-7222, 24 hours a day.

Source data: International Union Against Cancer http://www.uicc.org


'/>"/>
SOURCE MDS Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. Survival differences by race most apparent in advanced stages of breast cancer
3. MRI finds breast cancer before it becomes dangerous
4. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
5. Pathway links inflammation, angiogenesis and breast cancer
6. Radiologists encouraged to look beyond cancer for clinically unseen diseases
7. Diet high in meat, fat and refined grains linked to risk for colon cancer recurrence, death
8. Immune deficiency linked to a type of eye cancer
9. Drop in breast cancer incidence linked to hormone use, not mammograms
10. Breast cancer prevention practices vary across Canada
11. First biomarker discovered that predicts prostate cancer outcome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... that was developed to enhance the health of felines. The formula is all-natural and ... main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are ...
(Date:6/25/2016)... ... , ... Austin residents seeking Mohs surgery services, can now turn to Dr. ... Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include ... in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn ...
(Date:6/25/2016)... CA (PRWEB) , ... June 25, 2016 , ... As ... with Magna Cum Laude and his M.D from the David Geffen School of Medicine ... and returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Collagen Matrix, ... design, development and manufacturing of collagen and mineral ... announced today that Bill Messer has ... Marketing to further leverage the growing portfolio of ... devices. Bill joins the Collagen Matrix ...
(Date:6/24/2016)... -- The Academy of Managed Care Pharmacy (AMCP) today ... allow biopharmaceutical companies to more easily share health care ... coverage decisions, a move that addresses the growing need ... The recommendations address restrictions in the sharing of product ... a prohibition that hinders decision makers from accessing HCEI ...
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
Breaking Medicine Technology: